Genetic Association Analyses Highlight IL6, ALPL, and NAV1 As 3 New Susceptibility Genes Underlying Calcific Aortic Valve Stenosis.

BACKGROUND Calcific aortic valve stenosis (CAVS) is a frequent and life-threatening cardiovascular disease for which there is currently no medical treatment available. To date, only 2 genes, LPA and PALMD, have been identified as causal for CAVS. We aimed to identify additional susceptibility genes for CAVS. METHODS A GWAS (genome-wide association study) meta-analysis of 4 cohorts, totaling 5115 cases and 354 072 controls of European descent, was performed. A TWAS (transcriptome-wide association study) was completed to integrate transcriptomic data from 233 human aortic valves. A series of post-GWAS analyses were performed, including fine-mapping, colocalization, phenome-wide association studies, pathway, and tissue enrichment as well as genetic correlation with cardiovascular traits. RESULTS In the GWAS meta-analysis, 4 loci achieved genome-wide significance, including 2 new loci: IL6 (interleukin 6) on 7p15.3 and ALPL (alkaline phosphatase) on 1p36.12. A TWAS integrating gene expression from 233 human aortic valves identified NAV1 (neuron navigator 1) on 1q32.1 as a new candidate causal gene. The CAVS risk alleles were associated with higher mRNA expression of NAV1 in valve tissues. Fine-mapping identified rs1800795 as the most likely causal variant in the IL6 locus. The signal identified colocalizes with the expression of the IL6 RNA antisense in various tissues. Phenome-wide association analyses in the UK Biobank showed colocalized associations between the risk allele at the IL6 lead variant and higher eosinophil count, pulse pressure, systolic blood pressure, and carotid artery procedures, implicating modulation of the IL6 pathways. The risk allele at the NAV1 lead variant colocalized with higher pulse pressure and higher prevalence of carotid artery stenosis. Association results at the genome-wide scale indicated genetic correlation between CAVS, coronary artery disease, and cardiovascular risk factors. CONCLUSIONS Our study implicates 3 new genetic loci in CAVS pathogenesis, which constitute novel targets for the development of therapeutic agents.

[1]  A. Gusev,et al.  Probabilistic fine-mapping of transcriptome-wide association studies , 2017, Nature Genetics.

[2]  D. Rader,et al.  CXCL12 Derived From Endothelial Cells Promotes Atherosclerosis to Drive Coronary Artery Disease. , 2019, Circulation.

[3]  Julian M. W. Quinn,et al.  An atlas of genetic influences on osteoporosis in humans and mice , 2018, Nature Genetics.

[4]  A. Di Rienzo,et al.  Genetic variant at coronary artery disease and ischemic stroke locus 1p32.2 regulates endothelial responses to hemodynamics , 2018, Proceedings of the National Academy of Sciences.

[5]  K. Musunuru,et al.  Confirmation of Causal rs9349379-PHACTR1 Expression Quantitative Trait Locus in Human-Induced Pluripotent Stem Cell Endothelial Cells , 2018, Circulation. Genomic and precision medicine.

[6]  P. Schofield,et al.  Review and meta-analysis of genetic polymorphisms associated with exceptional human longevity , 2018, Mechanisms of Ageing and Development.

[7]  Christian Gieger,et al.  Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits , 2018, Nature Genetics.

[8]  M. Woodward,et al.  Elevated blood pressure and risk of aortic valve disease: a cohort analysis of 5.4 million UK adults , 2018, European heart journal.

[9]  Tianxi Cai,et al.  Association of Interleukin 6 Receptor Variant With Cardiovascular Disease Effects of Interleukin 6 Receptor Blocking Therapy: A Phenome-Wide Association Study , 2018, JAMA cardiology.

[10]  Joshua D. Hutcheson,et al.  Spatiotemporal Multi-Omics Mapping Generates a Molecular Atlas of the Aortic Valve and Reveals Networks Driving Disease , 2018, Circulation.

[11]  M. Kanai,et al.  Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases , 2018, Nature Genetics.

[12]  Pim van der Harst,et al.  Identification of 64 Novel Genetic Loci Provides an Expanded View on the Genetic Architecture of Coronary Artery Disease , 2017, Circulation research.

[13]  T. Sundt,et al.  Relationship Between Proximal Aorta Morphology and Progression Rate of Aortic Stenosis , 2017, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[14]  J. Smith,et al.  Familial Aggregation of Aortic Valvular Stenosis: A Nationwide Study of Sibling Risk , 2017, Circulation. Cardiovascular genetics.

[15]  G. Abecasis,et al.  Genome-wide analysis yields new loci associating with aortic valve stenosis , 2017, bioRxiv.

[16]  Nicola J. Rinaldi,et al.  Genetic effects on gene expression across human tissues , 2017, Nature.

[17]  S. Rose-John.  The Soluble Interleukin 6 Receptor: Advanced Therapeutic Options in Inflammation , 2017, Clinical pharmacology and therapeutics.

[18]  Y. Bossé,et al.  A transcriptome-wide association study identifies PALMD as a susceptibility gene for calcific aortic valve stenosis , 2017, bioRxiv.

[19]  Gregory A. Farnum,et al.  Protein-altering and regulatory genetic variants near GATA4 implicated in bicuspid aortic valve , 2017, Nature Communications.

[20]  M. Marz,et al.  Massive Effect on LncRNAs in Human Monocytes During Fungal and Bacterial Infections and in Response to Vitamins A and D , 2017, Scientific Reports.

[21]  N. Risch,et al.  Genome-wide association analyses using electronic health records identify new loci influencing blood pressure variation , 2016, Nature Genetics.

[22]  Marylyn D. Ritchie,et al.  Identifying Genetic Associations with Variability in Metabolic Health and Blood Count Laboratory Values: Diving into the Quantitative Traits by Leveraging Longitudinal Data from an EHR , 2017, PSB.

[23]  Yu Wang,et al.  AS‐IL6 promotes glioma cell invasion by inducing H3K27Ac enrichment at the IL6 promoter and activating IL6 transcription , 2016, FEBS letters.

[24]  Jie Huang,et al.  Discovery and refinement of genetic loci associated with cardiometabolic risk using dense imputation maps , 2016, Nature Genetics.

[25]  Alexander Gusev,et al.  Transcriptome-wide association study of schizophrenia and chromatin activity yields mechanistic disease insights , 2016, Nature Genetics.

[26]  O. Troyanskaya,et al.  Predicting effects of noncoding variants with deep learning–based sequence model , 2015, Nature Methods.

[27]  J. Hirschhorn,et al.  Biological interpretation of genome-wide association studies using predicted gene functions , 2015, Nature Communications.

[28]  M. Daly,et al.  LD Score regression distinguishes confounding from polygenicity in genome-wide association studies , 2014, Nature Genetics.

[29]  Ewan Birney,et al.  FORGE: A tool to discover cell specific enrichments of GWAS associated SNPs in regulatory regions , 2014, bioRxiv.

[30]  E. Eskin,et al.  Integrating Functional Data to Prioritize Causal Variants in Statistical Fine-Mapping Studies , 2014, PLoS genetics.

[31]  Y. Bossé,et al.  P2Y2 receptor represses IL-6 expression by valve interstitial cells through Akt: implication for calcific aortic valve disease. , 2014, Journal of molecular and cellular cardiology.

[32]  C. Wallace,et al.  Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics , 2013, PLoS genetics.

[33]  L. Liang,et al.  A functional IL-6 receptor (IL6R) variant is a risk factor for persistent atopic dermatitis. , 2013, The Journal of allergy and clinical immunology.

[34]  Kathleen F. Kerr,et al.  Genetic associations with valvular calcification and aortic stenosis. , 2013, The New England journal of medicine.

[35]  C. Irvin,et al.  Role of IL-6 in Asthma and Other Inflammatory Pulmonary Diseases , 2012, International journal of biological sciences.

[36]  Jennifer G. Robinson,et al.  The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis , 2012, The Lancet.

[37]  Christian Gieger,et al.  Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma , 2011, Nature Genetics.

[38]  R. Parker,et al.  Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials. , 2011, Rheumatology.

[39]  Hideo Orimo,et al.  The mechanism of mineralization and the role of alkaline phosphatase in health and disease. , 2010, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.

[40]  K. Teo,et al.  Effect of Lipid Lowering With Rosuvastatin on Progression of Aortic Stenosis: Results of the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) Trial , 2010, Circulation.

[41]  Jonathan C. Cohen,et al.  Targeted Deletion of the 9p21 Noncoding Coronary Artery Disease Risk Interval in Mice , 2010, Nature.

[42]  J. Chambers,et al.  Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. , 2008, The New England journal of medicine.

[43]  R. Bonow,et al.  Calcific aortic stenosis: an update , 2007, Nature Clinical Practice Cardiovascular Medicine.

[44]  V. Probst,et al.  Familial Aggregation of Calcific Aortic Valve Stenosis in the Western Part of France , 2006, Circulation.

[45]  D. Srivastava,et al.  Mutations in NOTCH1 cause aortic valve disease , 2005, Nature.

[46]  Rosario V. Freeman,et al.  Spectrum of Calcific Aortic Valve Disease: Pathogenesis, Disease Progression, and Treatment Strategies , 2005, Circulation.

[47]  R. Prescott,et al.  A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. , 2005, The New England journal of medicine.

[48]  C. Buesa,et al.  Neuron navigator: a human gene family with homology to unc-53, a cell guidance gene from Caenorhabditis elegans. , 2002, Genomics.

[49]  F. Green,et al.  Cooperative Influence of Genetic Polymorphisms on Interleukin 6 Transcriptional Regulation* , 2000, The Journal of Biological Chemistry.

[50]  J S Yudkin,et al.  The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. , 1998, The Journal of clinical investigation.